An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India

BACKGROUND: The bivalent killed oral cholera vaccine (OCV) provides 65% cumulative protection over five years. It remains unknown whether a boosting regimen can maintain protection in previously immunized populations. This study examines the immunogenicity and safety of an OCV regimen given five yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanungo, Suman, Desai, Sachin N., Saha, Jayanta, Nandy, Ranjan Kumar, Sinha, Anuradha, Kim, Deok Ryun, Bannerjee, Barnali, Manna, Byomkesh, Yang, Jae Seung, Ali, Mohammad, Sur, Dipika, Wierzba, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449043/
https://www.ncbi.nlm.nih.gov/pubmed/26023778
http://dx.doi.org/10.1371/journal.pntd.0003809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449043/
https://www.ncbi.nlm.nih.gov/pubmed/26023778
http://dx.doi.org/10.1371/journal.pntd.0003809

Ejemplares similares